Munther Al Najjar, Ph.D
Al Ain Campus
+971 3 7024871
Ph.D. Clinicl Pharmacy and Pharmacy Practice, School of Pharmacy, Queen’s University Belfast, UK
M.Sc. Pharmacy, University of Jordan, Jordan
B.Pharm. Philadelphia University, Jordan
Implementation / evaluation of several approaches to optimising antibiotic use and infection control. Evaluating and improving specific elements in antibiotic stewardship programme. Studying and analysis of epidemiological data with regards to antibiotic prescribing trends and variations in pathogen incidence rates throughout primary and secondary care settings.
M.S. Alnajjar, M.A. Aldeyab, M.G. Scott, M.P. Kearney, G. Fleming, F. Gallagher AND J.C. McElnay Incidence of catheter-related bloodstream infections. Hospital Pharmacy Europe Journal. Issue 81 (Spring 2016) Pages 41-47.
Pharmacotherapy courses, pharmacology, pharmacy practices in Hospitals.
Registered Pharmacist, Ministry of Health, Jordan, License No.: 5567
Registered pharmacist, Pharmaceutical Association, Jordan. Certificate No.: 5772
Registered specialist pharmacist, Saudi Council for Healthy Specialties, KSA. License No.: 04-R-P-22163
- Registered hospital pharmacist, Health Authority of Abu Dhabi (HAAD), United Arab Emirates. License No.: GP 12235
Influence of primary care antibiotic prescribing on incidence rates of bacteria in hospitalised patients
Published in: ESCP Conference in Clinical Pharmacy 24-27 October 2018
Nov 29, 2018
The 47th ESCP symposium on clinical pharmacy Personalised pharmacy care. 24–26 October 2018, Belfast, Northern Ireland. Influence of primary care antibiotic prescribing on incidence rates
Published in: International Journal of Clinical Pharmacy
Nov 29, 2018
The impact of an antibiotic policy on reducing high-risk antibiotic usage and on the incidence of MRSA and CDI at a teaching hospital in United Kingdom
Published in: Medication Safety Conference AbDhabi 2-4 November 2018
Nov 02, 2018
Published in: Journal of Pharmaceutical Health Services Research
Apr 30, 2018
Objective To investigate the effect of the Medication Management Review (MMR) service on the number of treatment‐related problems (TRPs), patient satisfaction and factors affecting patient satisfaction. Methods This prospective, randomized controlled trial was conducted at community pharmacies in Amman, Jordan. Eligible patients were randomized into active and control groups. A validated Pharmaceutical Care Manual was used for data collection and to identify TRPs for both groups. Identified TRPs for patients in the active group were resolved at the pharmacist level or sent to the patients’ physicians for approval and implementation. Patients in both groups were followed up at 3 months to determine the number of TRPs end of the study. Patients in the active group completed a validated, Likert scale MMR‐satisfaction questionnaire. Factors affecting satisfaction were assessed through multiple regression analysis. Key findings Outpatients with chronic conditions (n = 160) were recruited into the study, with mean age 53.01 ± 15.39; mean number of medical conditions of 3.56 ± 1.15 and 4.73 ± 1.79 mean number of medications. A mean number of 5.37 ± 3.01 TRPs per patient was identified, with no significant difference between both groups (active group n = 82, 5.57 ± 2.68; control n = 78, 5.18 ± 3.36, P = 0.412). At follow‐up, significantly lower number of TRPs were identified for patients in the active group compared to patients in the control group (1.06 ± 1.30 versus 4.53 ± 3.43, P < 0.001). Majority of patients were satisfied/very satisfied with the service (n = 77, 94.5%). A lower number of TRPs at follow‐up (B = −0.438; t = −4.477, P < 0.001) and higher number of TRPs agreed upon and implemented (B = 0.553; t = 6.949, P < 0.001) were significantly associated with higher level of patient satisfaction. Conclusion The MMR has proven to be an effective pharmaceutical care service when delivered in a developing country, such as Jordan. It led to high patient satisfaction, which was significantly associated with lower number of TRPs at follow‐up.
Published in: Hospital Pharmacy Europe
Mar 29, 2016